The Online Investor
MRK Buyback image

Merck Buyback

OLI recorded this information on 11/29/2017

Company: Merck
Buyback: MRK buyback
$Amount Authorized: $10,000,000,000
Buyback Details: Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.48 per outstanding share of the company's common stock, up $0.01 from $0.47 per outstanding share paid last quarter. Payment will be made on Jan. 8, 2018, to stockholders of record at the close of business on Dec. 15, 2017. The Board also authorized an additional $10 billion of treasury stock purchases with no time limit for completion.

Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.

Merck SEC Filing Email Alerts Service

Open the MRK Page at The Online Investor »

Company Name: 
Merck & Co Inc
Stock buyback: 
MRK buyback
Drugs & Pharmaceuticals
Number of ETFs Holding MRK: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the MRK Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree MRK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.11 out of 4)
25th percentile
(ranked lower than approx. 75% of all stocks covered)

Analysts' Target Price:
MRK Stock Forecast

Based on Zacks ABR data;
powered by Xignite

MRK Buyback Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.